WHO Expert Committee on Dependence-Producing Drugs

WHO Expert Committee on Dependence-Producing Drugs by WHO Expert Committee on Dependence-Producing Drugs. Download PDF EPUB FB2

In the 50 years since its first meeting, inthe WHO Expert Committee on Drug Dependence has played a central role in the international drug control system.

Its main task is to carry out medical and scientific evaluations of the abuse liability WHO Expert Committee on Dependence-Producing Drugs book dependence-producing drugs falling within the   WHO EXPERT COMMITTEE ON DRUG DEPENDENCE Thirty-fourth Report This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control.

The fi rst part of the report contains a summary of the Committee’s evaluations of seven substances This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control.

The first part of the report contains a description of the procedure for the review of dependence-producing subst This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control.

The first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine WHO Expert Committee on Drug Dependence. Thirty-second report. World Health Organization.

This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international control. The first part of the report contains a general discussion of the new WHO expert committee on dependence-producing drugs.

(PMID) Abstract Citations; Related Articles; Data; BioEntities; External Links; World Health Organization Technical Report Series [01 Jan] Type: Journal Article.

Abstract. No abstract provided. •) CitePeer Related Articles Reports of the Expert Committee on Drug Dependence From till now:: Report on the 39th session, Expert Committee on Drug Dependence ():: Report on the 38th session, Expert Committee on Drug Dependence ():: Report on the 37th session, Expert Committee on Drug Dependence ():: Report on the 36th session, Expert Committee on Drug Dependence ()   The WHO Expert Committee on Drug Dependence met in Geneva from 17 to 20 September The meeting was opened by Dr L.

Rägo, Coordinator, Quality Assurance and Safety: Medicines, who emphasized the significant role this Committee has played in the implementation of the international drug control system based on the existing drug control   In the 50 years since its first meeting inthe WHO Expert Committee on Drug Dependence (ECDD) has played a central role in the international drug control system.

Its main task is to carry out medical and scientific evaluations of the abuse liability of dependence-producing drugs falling within the terms of the Single Convention on Drugs (CND), the Expert Committee on Addiction-Producing Drugs (as the ECDD was named at the time) reported in its 12th report () that clarification on the chemical and pharmacological identification of the active principles of khat was needed before a sound   A WHO Expert Committee meeting on drug dependence was held in Geneva, Switzerland, from MarchThe Committee presented its 34th Report on the issues related to substance abuse.

The Report presents the recommendations of WHO Expert Committee responsible for reviewing the information on dependence-producing psychoactive substance in +Expert. WHO Expert Committee on Drug Dependence.

World Health Organization Expert Committee on Drug Dependence. This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international :// This Report by the WHO Expert Committee on Drug Dependence, which met in Geneva from 8 to 13 October,could be considered as a continuation of the Nineteenth Report, Technical Report Series No.

[Abstr. Hyg.,v. 48, abstr. ] because, whereas the previous one dealt mostly with the epidemiology of drug dependence, the present one is concerned principally with aetiology and The seventeenth report of the WHO Expert Committee on Drug Dependence is the result of the session at Geneva from 25th to 30th August The report starts by acknowledging the various bodies which have an interest in and are affected by the problems of drug dependence.

It also comments briefly on the Draft Protocol on Psychotropic Substances which has been forwarded for comments to   WHO Expert Committee on Drug Dependence. Thirty-third report WHO Technical Report Series, No.ISBN 92 4 1 (25 pages) WHO Expert Committee on Drug Dependence.

Thirty-second report WHO Technical Report Series, No.ISBN 92 4 8 (26 pages) WHO Expert Committee on Drug Dependence. Thirty-first report;sequence=1.

World Health Organ Tech Rep Ser. ; WHO expert committee on dependence-producing drugs. Fifteenth report. [No authors listed] The WHO Expert Committee was asked to make recommendations to the U.N.

Commission on Narcotic Drugs with regard to the dependence potential of substances, especially those used for medical and scientific purposes. Except for minor shortcomings, the report comes up to the usual high standards of these WHO reports. Section 3 of the report, dealing with animal studies, is ://   Narcotic Drugs as amended by the Protocol (the ^Single Convention _) (7).

Cannabis plant and cannabis resin have not been scientifically reviewed by the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) since the review by the Health Committee of the League of Nations in (7). In other contexts, abuse has referred to non-medical or unsanctioned patterns of use, irrespective of consequences.

Thus the definition published in by the WHO Expert Committee on Drug Dependence was “persistent or sporadic excessive drug use inconsistent with or unrelated to acceptable medical practice”*(see, misuse drug or alcohol).

Annotation. This report presents the recommendations of a WHO Expert Committee responsible for reviewing information on dependence-producing drugs to assess the need for their international first part of the report contains a summary of the Committee's evaluations of seven substances (dronabinol, oripavine, buprenorphine, butorphanol, ketamine, khat, and zopiclone).

Book: All Authors / Contributors: WHO Expert Committee on Drug Dependence. ISBN: OCLC Number: Notes: "The WHO Expert Committee on Drug Dependence met in Geneva from 28 to 31 March "--Page 1. Description: vi, 24 pages ; 24 cm.

Contents:The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD) reviewed the chemical composition of cannabis and its impact on the body in closed door sessions from November 12 to 16, and experts believe the groundswell of support will result in a downgrading of cannabis at international ://This Report, the result of a meeting of the WHO Expert Committee on Drug Dependence held from 21 to 27 Novemberaims at assessing ways in which the epidemiological approach could most usefully be applied to the study of problems in the field of drug dependence and considering means of increasing the number and comparability of such ://